13-48465022-G-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The ENST00000267163.6(RB1):c.2236G>T(p.Glu746Ter) variant causes a stop gained change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. E746E) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000267163.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.2236G>T | p.Glu746Ter | stop_gained | 22/27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.2236G>T | p.Glu746Ter | stop_gained | 22/27 | NP_001394094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.2236G>T | p.Glu746Ter | stop_gained | 22/27 | 1 | NM_000321.3 | ENSP00000267163 | P1 | |
RB1 | ENST00000650461.1 | c.2236G>T | p.Glu746Ter | stop_gained | 22/27 | ENSP00000497193 | ||||
RB1 | ENST00000643064.1 | c.194+83579G>T | intron_variant | ENSP00000496005 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 119674Hom.: 0 Cov.: 27 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 9.36e-7 AC: 1AN: 1068314Hom.: 0 Cov.: 37 AF XY: 0.00 AC XY: 0AN XY: 538268
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 119674Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 55000
ClinVar
Submissions by phenotype
Retinoblastoma Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine | May 20, 2024 | Case and Pedigree Information: BILATERAL CASES:1, UNILATERAL CASES:0, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:PVS1, PM2 - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 24, 2023 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1069507). This variant is also known as g.162021 G>T. This premature translational stop signal has been observed in individual(s) with retinoblastoma (PMID: 12173465, 28193182, 30636860). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu746*) in the RB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.